Skip to main content
. 2022 Jan 8;14(2):261. doi: 10.3390/nu14020261

Table 4.

Threshold intake of individual MDN associated with VOB-related HS 1,2.

Visceral Obesity Choline Intake 3
mg/kg Body Weight
Betaine Intake 4
mg/kg BW
Folate Intake 5
DFE ug/kg BW
Low
<6.9
High
≥6.9
Low
<3.1
High
≥3.1
Low
<8.8
High
≥8.8
Visceral adiposity grade
<10, n 47 51 46 52 46 50
≥10, n 76 33 80 29 73 36
Model A: OR (95%CI)
<0 (ref.) 1
(ref.)
0.85
(0.2–3.1)
1
(ref.)
1.2
(0.3–4.3)
1
(ref.)
1.08
(0.3–3.8)
≥10 22 *
(8.1–63)
10 *
(2.9–37)
26 *
(9.4–75)
12 *
(3.3–45)
26 *
(8.9–76)
13 *
(3.9–48)
Model B: OR (95%CI)
<10 (ref.) 1
(ref.)
1.33
(0.2–7.2)
1
(ref.)
1.0
(0.21–5.5)
1
(ref.)
2.6
(0.5–13)
≥10 22 *
(6.5–80)
9.6 *
(1.9–46)
14 *
(4.4–50)
14 *
(2.8–70)
19 *
(5.2–74)
30 *
(5.7–156)

1 Logistic regression models were constructed to evaluate threshold intake of MDN associated with visceral obesity (VOB)-related hepatic steatosis (HS). VOB was defined by visceral fat grade ≥10. Hepatic steatosis was diagnosed by sonography-graded fatty liver (yes or no). ORs of hepatic steatosis were considered to be statistically significant in relation to reference OR of 1 at * p < 0.05. 2 Multivariable logistic regression models were Model A: adjusted for age, sex, energy and fiber intake; Model B: additional adjustment of model A on blood triglyceride, blood cholesterol, HOMA-IR, and HbA1c. 3 Choline intake was stratified into the low (median 323; IQR: 244, 405 mg/d) and high intake (median: 603; IQR: 504, 720 mg/d) group at cutoff value of the controls’ median intake (6.9 mg/kg body weight = 406 mg/day). 4 Betaine intake was stratified into low (median 124; IQR: 82, 161 mg/d) and high intake (median 289; IQR: 233, 386 mg/d) at cutoff value of the controls’ median intake (3.1 mg/kg body weight = 178 mg/day). 5 Folate intake was stratified into low (median 320; IQR: 234, 421 DFE ug/d) and high intake (median 891; IQR: 289, 1211 DFE ug/d) at cutoff value of median intake of the control (8.8 ug/kg body weight = 527 DFE ug/day).